These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A conserved surface on the ligand binding domain of nuclear receptors for allosteric control. Buzón V; Carbó LR; Estruch SB; Fletterick RJ; Estébanez-Perpiñá E Mol Cell Endocrinol; 2012 Jan; 348(2):394-402. PubMed ID: 21878368 [TBL] [Abstract][Full Text] [Related]
7. Evolution of the repertoire of nuclear receptor binding sites in genomes. Cotnoir-White D; Laperrière D; Mader S Mol Cell Endocrinol; 2011 Mar; 334(1-2):76-82. PubMed ID: 21056084 [TBL] [Abstract][Full Text] [Related]
8. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design. Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255 [TBL] [Abstract][Full Text] [Related]
9. Compound profiling using a panel of steroid hormone receptor cell-based assays. Wilkinson JM; Hayes S; Thompson D; Whitney P; Bi K J Biomol Screen; 2008 Sep; 13(8):755-65. PubMed ID: 18753690 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of nuclear receptor-degradation inducers. Itoh Y; Kitaguchi R; Ishikawa M; Naito M; Hashimoto Y Bioorg Med Chem; 2011 Nov; 19(22):6768-78. PubMed ID: 22014751 [TBL] [Abstract][Full Text] [Related]
11. Emerging roles of the ubiquitin proteasome system in nuclear hormone receptor signaling. Lonard DM; O'Malley BW Prog Mol Biol Transl Sci; 2009; 87():117-35. PubMed ID: 20374703 [TBL] [Abstract][Full Text] [Related]
12. Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation. Zhou G; Cummings R; Hermes J; Moller DE Methods; 2001 Sep; 25(1):54-61. PubMed ID: 11558997 [TBL] [Abstract][Full Text] [Related]
13. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells. Awais M; Sato M; Umezawa Y Biosens Bioelectron; 2007 May; 22(11):2564-9. PubMed ID: 17095203 [TBL] [Abstract][Full Text] [Related]
14. Allosteric small molecule modulators of nuclear receptors. Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487 [TBL] [Abstract][Full Text] [Related]
15. Corepressor recruitment by agonist-bound nuclear receptors. White JH; Fernandes I; Mader S; Yang XJ Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453 [TBL] [Abstract][Full Text] [Related]
16. Chromatin remodeling and nuclear receptor signaling. Buranapramest M; Chakravarti D Prog Mol Biol Transl Sci; 2009; 87():193-234. PubMed ID: 20374705 [TBL] [Abstract][Full Text] [Related]
17. Modulation of nuclear receptor function: Targeting the protein-DNA interface. Veras Ribeiro Filho H; Tambones IL; Mariano Gonçalves Dias M; Bernardi Videira N; Bruder M; Amorim Amato A; Migliorini Figueira AC Mol Cell Endocrinol; 2019 Mar; 484():1-14. PubMed ID: 30703486 [TBL] [Abstract][Full Text] [Related]
18. Nuclear hormone receptor targeted virtual screening. Schapira M; Abagyan R; Totrov M J Med Chem; 2003 Jul; 46(14):3045-59. PubMed ID: 12825943 [TBL] [Abstract][Full Text] [Related]